Protection of mice against the intracellular bacterium Listeria monocytogenes by recombinant immune interferon
- 1 January 1984
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 14 (10) , 964-967
- https://doi.org/10.1002/eji.1830141019
Abstract
Immune interferon, available at high specific activity through recombinant DNA technology, is known to activate macrophages to intra‐ and extracellular cytotoxicity. We now report that murine recombinant IFN‐γ activates macrophages to cytotoxicity also when applied in vivo. Furthermore, recombinant IFN‐γ can protect mice in vivo against the intracellular bacterial pathogen Listeria monocytogenes in a local as well as in a systemic infection model. The role of T lymphocyte‐produced lymphokines in acquired resistance to facultative intracellular pathogens and their possible involvement in novel immunotherapy are discussed.Keywords
This publication has 11 references indexed in Scilit:
- Gamma-interferon is the factor in lymphokine that activates human macrophages to inhibit intracellular Chlamydia psittaci replication.The Journal of Immunology, 1983
- Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.The Journal of Experimental Medicine, 1983
- Recombinant mouse gamma interferon induces the priming step in macrophage activation for tumor cell killing.The Journal of Immunology, 1983
- Interferon-γ production byListeria monocytogenes-specific T cells active in cellular antibacterial immunityEuropean Journal of Immunology, 1983
- Biological functions of t cell lines with specificity for the intracellular bacterium Listeria monocytogenes in vitro and in vivo.The Journal of Experimental Medicine, 1982
- Production of high titers of interferon‐gamma by prestimulated murine spleen cellsEuropean Journal of Immunology, 1982
- The Role of Cell-Mediated Immunity in Bacterial InfectionsClinical Infectious Diseases, 1981
- Specific Lyt 123 cells are involved in protection against Listeria monocytogenes and in delayed-type hypersensitivity to listerial antigens.The Journal of Experimental Medicine, 1979
- CELLULAR RESISTANCE TO INFECTIONThe Journal of Experimental Medicine, 1962